By GREGORY ZELLER //
A Feinstein Institutes for Medical Research professor who’s dedicated his life to battling diabetes has earned a rare honor.
Endocrinologist Jesse Roth, a fellow of the American College of Physicians and head of the Laboratory for Diabetes and Diabetes-Related Research at the Feinstein Institutes’ Center for Biomedical Science, was honored Nov. 14 for his lifelong achievements in diabetes research at the ninth D-Cure Symposium in Israel.
D-Cure is focused on advancing diabetes research in Israel and translating new discoveries into state-of-the-art patient care – and Roth, a professor at both Northwell Health’s Elmezzi Graduate School of Molecular Medicine and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell “has been active in the D-Cure organization since its beginning, and has been an integral part of its success,” according to the group.
“This symposium is dedicated to celebrate Jesse’s many achievements and his outstanding contributions to diabetes research, education and innovation worldwide and in Israel,” D-Cure President Itamar Raz said in a statement.
Roth, who keynoted a symposium packed with international guest lecturers and poster sessions, has spent more than five decades researching diabetes and related conditions. His big-picture idea has been early diagnosis and prevention; his legendary lab work has hastened critical discoveries, insulin receptors and their critical role among them.
“Finding better ways to prevent and manage diabetes has been my lifelong mission,” noted Roth, who earned his MD in 1959 from the Albert Einstein College of Medicine in the Bronx and has been subsequently graced with honorary doctorates from five additional universities.
“I am humbled by this recognition, and thankful to be sharing the occasion with esteemed colleagues and friends,” Roth added.
Prior to joining Northwell Health (then the North Shore/LIJ Health System) in 2000, the one-time assistant surgeon general of the U.S. Public Health Service held several key executive positions, including leadership roles at the National Institutes of Health and Johns Hopkins Medicine.
Roth, also a well-known mentor of young scientists under his charge, “embodies our mission of producing knowledge to cure disease,” according to Feinstein Institutes President and CEO Kevin Tracey.
“His lifetime contributions to understanding diabetes continue to lay the groundwork for future advancements,” Tracey added.